OBJECTIVES: To determine the incidence of malignancy (invasive carcinoma or DCIS) in
patients diagnosed with lobular neoplasia (B3) on core needle biopsy (CNB) of breast …

Lobular neoplasia of the breast represents a group of related malignancies with clinical
implications ranging from risk lesions [atypical lobular hyperplasia and lobular carcinoma in …

BACKGROUND Lobular neoplasia (LN), also known as lobular carcinoma in situ, is an
incidental histologic finding in tissue removed at breast surgery. Patients with LN are known …

OBJECTIVE. Atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), and
lobular carcinoma in situ (LCIS) are among high-risk lesions that have been previously …

Abstract Purpose of Review The aim of this review is to summarize recently published
literature addressing atypical ductal hyperplasia (ADH), lobular neoplasia (atypical lobular …

Purpose Controversy surrounds management of lobular neoplasia (LN),[atypical lobular
hyperplasia (ALH) or lobular carcinoma in situ (LCIS)], diagnosed on core needle biopsy …

We have stratified the cancer risk implications of lobular pattern in situ neoplasias of the
breast by separating marked examples of this histologic spectrum (lobular carcinoma in situ …

Lobular neoplasia, which encompasses both atypical lobular hyperplasia and lobular
carcinoma in situ, is traditionally considered a risk lesion that indicates an increased relative …

One of the most remarkable things about invasive lobular carcinoma and its certain
nonobligate precursors (atypical lobular hyperplasia [ALH] and lobular carcinomain-situ …

Background Using new molecular biology techniques, recent studies have implicated a
common evolutionary pathway between lobular neoplasia, lobular carcinomas, and …